Business Context and Reporting Period
This Form 8-K Current Report from Tempest Therapeutics, Inc. (TPST) covers events occurring on July 27, 2026. The filing details the outcome of a Special Meeting of stockholders convened to vote on a Certificate of Amendment to the Company's Restated Certificate of Incorporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
- Proposal Status: The proposal to replace supermajority voting requirements and permit stockholder action by written consent was not approved at the July 27, 2026 meeting due to insufficient votes.
- Quorum and Participation: A total of 10,031,446 shares (67.7% of the 14,806,997 shares outstanding as of the May 28, 2026 record date) were present or represented by proxy, constituting a quorum.
- Voting Threshold: The Proposal requires the affirmative vote of at least 75% of the votes entitled to be cast.
- Adjournment: The Special Meeting was adjourned to allow additional time for voting and broader participation.
Outlook, Management Commentary, and Risks
Management has scheduled a reconvened Special Meeting for August 17, 2026, at 12:00 p.m. Eastern Time via live webcast. No changes have been made to the Proposal. The Company has engaged Sodali & Co., a proxy solicitation firm, to assist in obtaining adequate votes. Investors are urged to review the definitive proxy statement for detailed information regarding the matters to be voted on.
Key Facts for Investor Verification
- Verify the outcome of the reconvened Special Meeting scheduled for August 17, 2026.
- Review the definitive proxy statement filed on July 17, 2026, for details on the proposed Certificate of Amendment.
- Confirm the current status of the 75% supermajority voting requirement and written consent provisions.
- Monitor for any updates regarding the engagement of proxy solicitation firms and their impact on vote totals.